BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25772509)

  • 21. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action.
    Degroot A; Köfalvi A; Wade MR; Davis RJ; Rodrigues RJ; Rebola N; Cunha RA; Nomikos GG
    Mol Pharmacol; 2006 Oct; 70(4):1236-45. PubMed ID: 16855179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease.
    Oliver EE; Hughes EK; Puckett MK; Chen R; Lowther WT; Howlett AC
    Biomolecules; 2020 Nov; 10(12):. PubMed ID: 33261012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures.
    Bojnik E; Turunç E; Armağan G; Kanıt L; Benyhe S; Yalçın A; Borsodi A
    Epilepsy Res; 2012 Mar; 99(1-2):64-8. PubMed ID: 22079489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anatomically heterogeneous populations of CB1 cannabinoid receptor-expressing interneurons in the CA3 region of the hippocampus show homogeneous input-output characteristics.
    Szabó GG; Papp OI; Máté Z; Szabó G; Hájos N
    Hippocampus; 2014 Dec; 24(12):1506-23. PubMed ID: 25044969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation.
    Inada H; Maejima T; Nakahata Y; Yamaguchi J; Nabekura J; Ishibashi H
    Neuroscience; 2010 Feb; 165(4):1377-89. PubMed ID: 19961906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of diacylglycerol lipase in constitutive and angiotensin AT1 receptor-stimulated cannabinoid CB1 receptor activity.
    Turu G; Simon A; Gyombolai P; Szidonya L; Bagdy G; Lenkei Z; Hunyady L
    J Biol Chem; 2007 Mar; 282(11):7753-7. PubMed ID: 17227758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The endocannabinoid system regulates the moderate exercise-induced enhancement of learning and memory in mice.
    Wang H; Han J
    J Sports Med Phys Fitness; 2020 Feb; 60(2):320-328. PubMed ID: 31974335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
    Eldeeb K; Leone-Kabler S; Howlett AC
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SGIP1 alters internalization and modulates signaling of activated cannabinoid receptor 1 in a biased manner.
    Hájková A; Techlovská Š; Dvořáková M; Chambers JN; Kumpošt J; Hubálková P; Prezeau L; Blahos J
    Neuropharmacology; 2016 Aug; 107():201-214. PubMed ID: 26970018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippocampal cannabinoid transmission modulates dopamine neuron activity: impact on rewarding memory formation and social interaction.
    Loureiro M; Renard J; Zunder J; Laviolette SR
    Neuropsychopharmacology; 2015 May; 40(6):1436-47. PubMed ID: 25510937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-LINGO-1 antibody ameliorates cognitive impairment, promotes adult hippocampal neurogenesis, and increases the abundance of CB1R-rich CCK-GABAergic interneurons in AD mice.
    He Q; Jiang L; Zhang Y; Yang H; Zhou CN; Xie YH; Luo YM; Zhang SS; Zhu L; Guo YJ; Deng YH; Liang X; Xiao Q; Zhang L; Tang J; Huang DJ; Zhou YN; Dou XY; Chao FL; Tang Y
    Neurobiol Dis; 2021 Aug; 156():105406. PubMed ID: 34044148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of nitric oxide in depolarization-induced suppression of inhibition in hippocampal pyramidal cells during activation of cholinergic receptors.
    Makara JK; Katona I; Nyíri G; Németh B; Ledent C; Watanabe M; de Vente J; Freund TF; Hájos N
    J Neurosci; 2007 Sep; 27(38):10211-22. PubMed ID: 17881527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus.
    Neu A; Földy C; Soltesz I
    J Physiol; 2007 Jan; 578(Pt 1):233-47. PubMed ID: 17053036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
    Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine A
    Aso E; Fernández-Dueñas V; López-Cano M; Taura J; Watanabe M; Ferrer I; Luján R; Ciruela F
    Mol Neurobiol; 2019 Aug; 56(8):5382-5391. PubMed ID: 30610611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
    Musella A; Sepman H; Mandolesi G; Gentile A; Fresegna D; Haji N; Conrad A; Lutz B; Maccarrone M; Centonze D
    Neuropharmacology; 2014 Apr; 79():567-72. PubMed ID: 24440366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental Switch in Spike Timing-Dependent Plasticity and Cannabinoid-Dependent Reorganization of the Thalamocortical Projection in the Barrel Cortex.
    Itami C; Huang JY; Yamasaki M; Watanabe M; Lu HC; Kimura F
    J Neurosci; 2016 Jun; 36(26):7039-54. PubMed ID: 27358460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CB1 cannabinoid receptors and on-demand defense against excitotoxicity.
    Marsicano G; Goodenough S; Monory K; Hermann H; Eder M; Cannich A; Azad SC; Cascio MG; Gutiérrez SO; van der Stelt M; López-Rodriguez ML; Casanova E; Schütz G; Zieglgänsberger W; Di Marzo V; Behl C; Lutz B
    Science; 2003 Oct; 302(5642):84-8. PubMed ID: 14526074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular-interaction and signaling profiles of AM3677, a novel covalent agonist selective for the cannabinoid 1 receptor.
    Janero DR; Yaddanapudi S; Zvonok N; Subramanian KV; Shukla VG; Stahl E; Zhou L; Hurst D; Wager-Miller J; Bohn LM; Reggio PH; Mackie K; Makriyannis A
    ACS Chem Neurosci; 2015 Aug; 6(8):1400-10. PubMed ID: 25978068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.